(Medical Xpress)—A new cancer drug, based on further development of a discovery originally made by Cancer Research UK, has entered a clinical trial to target a wide range of cancers.
Mar 28, 2014
4.8 / 5 (5) | 0
Celldex Therapeutics announced today that final data from its Phase 1 study of CDX-1401 in solid tumors, including long-term patient follow-up, have been published in Science Translational Medicine. The da ...
Apr 16, 2014
4 / 5 (1) | 1